Peng Zhou develops cross-domain biosensing platforms for healthcare and environmental monitoring. He secured $1.45M+ for wastewater metagenomics and rapid surveillance and holds a provisional patent for rapid field COVID-19 testing. Recent work includes CRISPR-based lateral flow and multiplex fluorescence assays.